Tag: brokerage

Net Income per Diluted Share of $10.02 for the Quarter, inclusive of Income from Discontinued Operations

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NYSE: VIRT), a leading provider of financial services and products that leverages cutting edge technology to deliver innovative, transparent trading solutions to its clients and liquidity to the global markets, today reported results for the second quarter ended June 30, 2025.

COLUMBUS, Ohio, July 29, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the launch of reAlpha Mortgage, the next chapter in the evolution of its mortgage division. Unifying both realty and mortgage services under the reAlpha brand reflects the company’s ongoing strategy to deliver a seamless, technology-enabled homebuying experience by aligning its operations under a single, more powerful platform.

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- GraniteShares has announced it will execute a reverse share split for the GraniteShares 2x Short COIN (the “Fund”). The total market value of the shares outstanding will not be affected as a result of the reverse split.

As Managing Director, Sanford will guide the evolution of SUCCESS+ with cutting-edge AI tools designed to elevate personal growth, performance, and impact

Toronto, July 25, 2025 (GLOBE NEWSWIRE) -- Faircourt Asset Management Inc., as Manager of the Faircourt Fund (CBOE:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund.

New York, July 25, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") for its client Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), a Hong Kong-based financial services provider.

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12 (the “Reverse Stock Split”). The Company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5, 2025 under the existing symbol of “CLDI.” The new CUSIP number for the Company’s common stock following the Reverse Stock Split will be 320703 408.